B9Creations
Develops high-precision DLP 3D printers and resins for medical and industrial production, emphasizing speed and out-of-the-box productivity.
- CEO / Founder
- Shon Anderson
- Team Size
- 51-200
- Stage
- Active
- Total Funding
- $1.45M
- Latest Round
- Strategic Investment
- Key Investors
- Mitsui Chemicals; Paycheck Protection Program
Technology & Products
Key Products
B9 Core Series 3D printers, B9Creator, B9Scan, B9Clean, B9Cure, and proprietary resins.
Technological Advantage
Proprietary fleet management features including printer fingerprinting and QA/QC standardization for distributed manufacturing.
Differentiation
Value Proposition
Provides production-ready DLP platforms that offer the fastest print speeds for high-resolution parts, enabling rapid prototyping and scaled manufacturing with biocompatible materials.
How They Differentiate
Focuses on out-of-the-box productivity and speed for medical/industrial sectors compared to general-purpose DLP systems.
Market & Competition
Target Customers
Medical device manufacturers, Fortune 500 companies, jewelry designers, and industrial manufacturers.
Industry Verticals
Medical; Dental; Jewelry; Industrial; Research
Competitors
EnvisionTEC (ETEC); Asiga; SprintRay
Growth & Milestones
Growth Metrics
Annual revenue ~$22M (2025 estimate); serves thousands of customers in 66+ countries.
Major Milestones
2011 Kickstarter launch; 2016 CEO transition; North Texas office opening; B9[x] largest-format printer unveil; Würth partnership for distributed AM
Notable Customers
Medtronic, Johnson & Johnson, 3M, Procter & Gamble, and over 100 educational customers including K-12, Higher Education, and Research Labs.